Anika Therapeutics Inc.
15.59
-0.33 (-2.07%)
At close: Jan 14, 2025, 3:59 PM
15.58
-0.06%
After-hours Jan 14, 2025, 04:00 PM EST

Anika Therapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021
Joint Preservation and Restoration Revenue 11.95M 13.84M 15.30M 13.47M 12.66M 13.45M 14.35M 11.82M 12.10M 12.14M 13.29M 11.19M 11.88M 12.22M
Joint Preservation and Restoration Revenue Growth -13.66% -9.51% +13.56% +6.40% -5.89% -6.23% +21.37% -2.27% -0.36% -8.67% +18.75% -5.81% -2.74% n/a
Non-Orthopedic Revenue 2.38M 2.36M 2.60M 3.11M 2.31M 1.84M 1.53M 2.78M 1.82M 1.82M n/a n/a n/a n/a
Non-Orthopedic Revenue Growth +0.47% -9.18% -16.22% +34.62% +25.57% +20.37% -45.03% +52.55% 0.00% n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2012
Europe Revenue 21.72M 20.64M 19.58M 14.18M 14.74M 11.73M 12.44M 10.95M 8.76M 6.21M 6.27M
Europe Revenue Growth +5.26% +5.41% +38.09% -3.83% +25.69% -5.67% +13.53% +25.09% +40.90% -0.85% n/a
United States Revenue 123.13M 119.15M 113.83M 103.18M 90.30M 85.35M 92.91M 83.97M 76.62M n/a n/a
United States Revenue Growth +3.34% +4.67% +10.32% +14.26% +5.80% -8.13% +10.64% +9.59% n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 19.11M 19.81M 21.53M 20.34M 24.83M 23.69M 27.00M 23.05M 21.28M 21.27M 19.20M 20.43M 17.50M 17.99M 18.18M 15.18M 15.90M 14.55M 14.43M 12.24M 7.54M 7.50M 7.67M 6.13M 5.70M 6.42M 16.09M 6.68M 4.82M 4.97M 5.07M 5.49M 4.28M 4.25M 3.99M 4.52M 3.31M 3.39M 3.60M
Selling, General, and Administrative Revenue Growth -3.50% -7.99% +5.86% -18.09% +4.80% -12.25% +17.12% +8.33% +0.04% +10.77% -6.02% +16.75% -2.72% -1.02% +19.74% -4.55% +9.30% +0.82% +17.93% +62.32% +0.49% -2.22% +25.18% +7.53% -11.17% -60.12% +140.94% +38.46% -3.00% -1.87% -7.67% +28.22% +0.59% +6.64% -11.80% +36.73% -2.35% -6.00% n/a
Research and Development Revenue 7.24M 7.40M 8.16M 7.58M 7.79M 8.91M 8.40M 7.75M 7.30M 6.97M 6.16M 6.00M 7.67M 7.29M 6.36M 7.63M 5.22M 4.53M 6.05M 4.08M 4.16M 4.17M 4.26M 4.06M 4.23M 4.73M 5.16M 4.27M 5.84M 4.45M 4.23M 2.96M 2.82M 2.79M 2.16M 3.02M 2.06M 1.81M 2.10M
Research and Development Revenue Growth -2.08% -9.38% +7.63% -2.64% -12.60% +6.12% +8.40% +6.14% +4.67% +13.29% +2.62% -21.80% +5.21% +14.65% -16.65% +46.29% +15.11% -25.09% +48.14% -1.78% -0.17% -2.18% +4.77% -3.97% -10.59% -8.29% +20.98% -26.98% +31.31% +5.18% +42.95% +4.85% +1.07% +29.32% -28.42% +46.29% +13.76% -13.61% n/a

Create Price Alert on ANIK

Your price alert will notify you when the stock price is above 15.59.

Add to Watchlist